Rhabdomyosarcoma of the ear in childhood. A report from the intergroup rhabdomyosarcoma study‐I

R. Beverly Raney, Walter Lawrence, Harold Maurice Maurer, Robert D. Lindberg, William A. Newton, Abdelsalam H. Ragab, Melvin Tefft, Mary A. Foulkes

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Twenty‐four children with rhabdomyosarcoma of the middle (22 patients) or external ear (two patients) were entered on the Intergroup Rhabdomyosarcoma Study‐I protocol from 1972 to 1978. After surgery, treatment consisted of radiotherapy plus vincristine, dactinyomycin, and cyclophosphamide, with or without Adriamycin. Nine of 19 patients (47%) who presented with localized sarcoma are free of disease at 2.2 to 6.5 years after diagnosis (median, 3.6 years). One is alive with regional recurrence at 6.7 years; another developed a contralateral cerebellar astrocytoma 4.4 years from diagnosis and died without evidence of rhabdomyosarcoma 2 months later. The other 13 children died of recurrent rhabdomyosarcoma at 5 to 25 months after diagnosis (median duration of survival, 10 months). Outcome was influenced by the presence of diagnosis of signs indicating meningeal extension; death rates were 5 of 5 patients with intracranial tumor, 3 of 4 with petrous bone erosion, 2 of 6 with facial nerve palsy, and 3 of 9 with no initial evidence of meningeal extension.

Original languageEnglish (US)
Pages (from-to)2356-2361
Number of pages6
JournalCancer
Volume51
Issue number12
DOIs
StatePublished - Jan 1 1983

Fingerprint

Rhabdomyosarcoma
Ear
Alveolar Rhabdomyosarcoma
Petrous Bone
External Ear
Facial Paralysis
Astrocytoma
Facial Nerve
Vincristine
Sarcoma
Doxorubicin
Cyclophosphamide
Radiotherapy
Recurrence
Survival
Mortality
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Raney, R. B., Lawrence, W., Maurer, H. M., Lindberg, R. D., Newton, W. A., Ragab, A. H., ... Foulkes, M. A. (1983). Rhabdomyosarcoma of the ear in childhood. A report from the intergroup rhabdomyosarcoma study‐I. Cancer, 51(12), 2356-2361. https://doi.org/10.1002/1097-0142(19830615)51:12<2356::AID-CNCR2820511232>3.0.CO;2-L

Rhabdomyosarcoma of the ear in childhood. A report from the intergroup rhabdomyosarcoma study‐I. / Raney, R. Beverly; Lawrence, Walter; Maurer, Harold Maurice; Lindberg, Robert D.; Newton, William A.; Ragab, Abdelsalam H.; Tefft, Melvin; Foulkes, Mary A.

In: Cancer, Vol. 51, No. 12, 01.01.1983, p. 2356-2361.

Research output: Contribution to journalArticle

Raney, RB, Lawrence, W, Maurer, HM, Lindberg, RD, Newton, WA, Ragab, AH, Tefft, M & Foulkes, MA 1983, 'Rhabdomyosarcoma of the ear in childhood. A report from the intergroup rhabdomyosarcoma study‐I', Cancer, vol. 51, no. 12, pp. 2356-2361. https://doi.org/10.1002/1097-0142(19830615)51:12<2356::AID-CNCR2820511232>3.0.CO;2-L
Raney, R. Beverly ; Lawrence, Walter ; Maurer, Harold Maurice ; Lindberg, Robert D. ; Newton, William A. ; Ragab, Abdelsalam H. ; Tefft, Melvin ; Foulkes, Mary A. / Rhabdomyosarcoma of the ear in childhood. A report from the intergroup rhabdomyosarcoma study‐I. In: Cancer. 1983 ; Vol. 51, No. 12. pp. 2356-2361.
@article{c86fdb57c86e416594c96b7e2709a4b5,
title = "Rhabdomyosarcoma of the ear in childhood. A report from the intergroup rhabdomyosarcoma study‐I",
abstract = "Twenty‐four children with rhabdomyosarcoma of the middle (22 patients) or external ear (two patients) were entered on the Intergroup Rhabdomyosarcoma Study‐I protocol from 1972 to 1978. After surgery, treatment consisted of radiotherapy plus vincristine, dactinyomycin, and cyclophosphamide, with or without Adriamycin. Nine of 19 patients (47{\%}) who presented with localized sarcoma are free of disease at 2.2 to 6.5 years after diagnosis (median, 3.6 years). One is alive with regional recurrence at 6.7 years; another developed a contralateral cerebellar astrocytoma 4.4 years from diagnosis and died without evidence of rhabdomyosarcoma 2 months later. The other 13 children died of recurrent rhabdomyosarcoma at 5 to 25 months after diagnosis (median duration of survival, 10 months). Outcome was influenced by the presence of diagnosis of signs indicating meningeal extension; death rates were 5 of 5 patients with intracranial tumor, 3 of 4 with petrous bone erosion, 2 of 6 with facial nerve palsy, and 3 of 9 with no initial evidence of meningeal extension.",
author = "Raney, {R. Beverly} and Walter Lawrence and Maurer, {Harold Maurice} and Lindberg, {Robert D.} and Newton, {William A.} and Ragab, {Abdelsalam H.} and Melvin Tefft and Foulkes, {Mary A.}",
year = "1983",
month = "1",
day = "1",
doi = "10.1002/1097-0142(19830615)51:12<2356::AID-CNCR2820511232>3.0.CO;2-L",
language = "English (US)",
volume = "51",
pages = "2356--2361",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "12",

}

TY - JOUR

T1 - Rhabdomyosarcoma of the ear in childhood. A report from the intergroup rhabdomyosarcoma study‐I

AU - Raney, R. Beverly

AU - Lawrence, Walter

AU - Maurer, Harold Maurice

AU - Lindberg, Robert D.

AU - Newton, William A.

AU - Ragab, Abdelsalam H.

AU - Tefft, Melvin

AU - Foulkes, Mary A.

PY - 1983/1/1

Y1 - 1983/1/1

N2 - Twenty‐four children with rhabdomyosarcoma of the middle (22 patients) or external ear (two patients) were entered on the Intergroup Rhabdomyosarcoma Study‐I protocol from 1972 to 1978. After surgery, treatment consisted of radiotherapy plus vincristine, dactinyomycin, and cyclophosphamide, with or without Adriamycin. Nine of 19 patients (47%) who presented with localized sarcoma are free of disease at 2.2 to 6.5 years after diagnosis (median, 3.6 years). One is alive with regional recurrence at 6.7 years; another developed a contralateral cerebellar astrocytoma 4.4 years from diagnosis and died without evidence of rhabdomyosarcoma 2 months later. The other 13 children died of recurrent rhabdomyosarcoma at 5 to 25 months after diagnosis (median duration of survival, 10 months). Outcome was influenced by the presence of diagnosis of signs indicating meningeal extension; death rates were 5 of 5 patients with intracranial tumor, 3 of 4 with petrous bone erosion, 2 of 6 with facial nerve palsy, and 3 of 9 with no initial evidence of meningeal extension.

AB - Twenty‐four children with rhabdomyosarcoma of the middle (22 patients) or external ear (two patients) were entered on the Intergroup Rhabdomyosarcoma Study‐I protocol from 1972 to 1978. After surgery, treatment consisted of radiotherapy plus vincristine, dactinyomycin, and cyclophosphamide, with or without Adriamycin. Nine of 19 patients (47%) who presented with localized sarcoma are free of disease at 2.2 to 6.5 years after diagnosis (median, 3.6 years). One is alive with regional recurrence at 6.7 years; another developed a contralateral cerebellar astrocytoma 4.4 years from diagnosis and died without evidence of rhabdomyosarcoma 2 months later. The other 13 children died of recurrent rhabdomyosarcoma at 5 to 25 months after diagnosis (median duration of survival, 10 months). Outcome was influenced by the presence of diagnosis of signs indicating meningeal extension; death rates were 5 of 5 patients with intracranial tumor, 3 of 4 with petrous bone erosion, 2 of 6 with facial nerve palsy, and 3 of 9 with no initial evidence of meningeal extension.

UR - http://www.scopus.com/inward/record.url?scp=0020630752&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020630752&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(19830615)51:12<2356::AID-CNCR2820511232>3.0.CO;2-L

DO - 10.1002/1097-0142(19830615)51:12<2356::AID-CNCR2820511232>3.0.CO;2-L

M3 - Article

VL - 51

SP - 2356

EP - 2361

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 12

ER -